The estimated Net Worth of Susan K Whoriskey is at least $4.34 millió dollars as of 17 April 2007. Susan Whoriskey owns over 6,666 units of Momenta Pharmaceuticals stock worth over $3,612,251 and over the last 20 years Susan sold MNTA stock worth over $723,874.
Susan has made over 7 trades of the Momenta Pharmaceuticals stock since 2006, according to the Form 4 filled with the SEC. Most recently Susan sold 6,666 units of MNTA stock worth $99,390 on 17 April 2007.
The largest trade Susan's ever made was selling 6,666 units of Momenta Pharmaceuticals stock on 17 April 2007 worth over $99,390. On average, Susan trades about 4,165 units every 31 days since 2004. As of 17 April 2007 Susan still owns at least 68,831 units of Momenta Pharmaceuticals stock.
You can see the complete history of Susan Whoriskey stock trades at the bottom of the page.
Susan's mailing address filed with the SEC is C/O MOMENTA PHARMACEUTICALS, INC., 43 MOULTON STREET, CAMBRIDGE, MA, 02138.
Over the last 20 years, insiders at Momenta Pharmaceuticals have traded over $110,027,424 worth of Momenta Pharmaceuticals stock and bought 827,300 units worth $5,505,611 . The most active insiders traders include Christoph H Westphal, Craig A Wheeler és Peter Barrett. On average, Momenta Pharmaceuticals executives and independent directors trade stock every 6 days with the average trade being worth of $448,442. The most recent stock trade was executed by Ian Fier on 20 August 2020, trading 1,808 units of MNTA stock currently worth $94,323.
Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.
Momenta Pharmaceuticals executives and other stock owners filed with the SEC include: